EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Tetracyclines, a timely resurgence or doomed to fail again?

Samuel Fenn, Dimitra Panagiotopoulou, Kim R. Hardie

Journal of Medical Microbiology · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Graphical Abstract Brief diagrammatic overview of tetracyclines structure, mode of action, side-effects, spectrum of action and administration. Tetracyclines are type II polyketides consisting of four fused rings, with an oxygen-rich ‘non-modifiable’ region required to maintain antimicrobial activity. Tetracyclines target the prokaryotic ribosome by binding the 30S subunit, inhibiting polypeptide elongation. These antimicrobials have a broad spectrum of activity targeting Gram-positive and Gram-negative bacteria alongside eukaryotic parasites. Tetracyclines are administered both orally and intravenously and cause a wide range of side effects, primarily driven by the ability of tetracycline to chelate essential metal ions and bind to the mitochondrial ribosomes. The graphics were created in BioRender. Fenn, S. (2026) https://BioRender.com/fdhfh5s

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Samuel Fenn, Dimitra Panagiotopoulou, Kim R. Hardie
Quelle
Journal of Medical Microbiology
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0022-2615, 1473-5644
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Samuel Fenn, Dimitra Panagiotopoulou, Kim R. Hardie (2026). Tetracyclines, a timely resurgence or doomed to fail again?. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002197
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1